These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 10623331)

  • 21. Inhaled corticosteroids for adult asthma: impact of formulation and delivery device on relative pharmacokinetics, efficacy and safety.
    Shaw RJ
    Respir Med; 1999 Mar; 93(3):149-60. PubMed ID: 10464870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Switch to non-CFC inhaled corticosteroids: a comparative efficacy study of HFA-BDP and CFC-BDP metered-dose inhalers.
    Demedts M; Cohen R; Hawkinson R
    Int J Clin Pract; 1999; 53(5):331-8. PubMed ID: 10695095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New delivery systems and propellants.
    Dolovich M
    Can Respir J; 1999; 6(3):290-5. PubMed ID: 10393290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting inhaled steroids.
    Leach C
    Int J Clin Pract Suppl; 1998 Sep; 96():23-7. PubMed ID: 10344030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tolerability and in vivo performance of a novel freon-free metered dose inhaler for a fixed combinational product of reproterol and disodium cromoglycate.
    Hermann R; Ruus P; Schneider E; de Mey C
    Arzneimittelforschung; 1998 Jun; 48(6):663-7. PubMed ID: 9689424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic differences between chlorofluorocarbon and chlorofluorocarbon-free metered dose inhalers of beclomethasone dipropionate in adult asthmatics.
    Harrison LI; Soria I; Cline AC; Ekholm BP
    J Pharm Pharmacol; 1999 Nov; 51(11):1235-40. PubMed ID: 10632080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compatibility evaluation of metered-dose inhaler valve elastomers with tetrafluoroethane (P134a), a non-CFC propellant.
    Tiwari D; Goldman D; Dixit S; Malick WA; Madan PL
    Drug Dev Ind Pharm; 1998 Apr; 24(4):345-52. PubMed ID: 9876594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The equivalent bronchodilator effects of salbutamol formulated in chlorofluorocarbon and hydrofluoroalkane-134a metered dose inhalers on the histamine-induced pulmonary response in dogs.
    Nogami-Itoh M; Yakuo I; Hammerbeck DM; Miller RL; Takeyama K
    Pharm Res; 1997 Feb; 14(2):208-12. PubMed ID: 9090711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preliminary data from phase II studies with Respimat, a propellant-free soft mist inhaler.
    Pavia D; Moonen D
    J Aerosol Med; 1999; 12 Suppl 1():S33-9. PubMed ID: 10623340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic concentrations of salbutamol and HFA-134a after inhalation of salbutamol sulfate in a chlorofluorocarbon-free system.
    Harrison LI; Cline A; Wells TM; Jacobson JP; Cooper KM; Chang SF; Nelson JR; Ekholm BP; Morganroth J
    Ther Drug Monit; 1996 Jun; 18(3):240-4. PubMed ID: 8738762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cumulative dose response study comparing HFA-134a albuterol sulfate and conventional CFC albuterol in patients with asthma.
    Ramsdell JW; Colice GL; Ekholm BP; Klinger NM
    Ann Allergy Asthma Immunol; 1998 Dec; 81(6):593-9. PubMed ID: 9892032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuing patient care with metered-dose inhalers.
    Woodcock A
    J Aerosol Med; 1995; 8 Suppl 2():S5-10. PubMed ID: 10155357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cumulative dose-response study of non-CFC propellant HFA 134a salbutamol sulfate metered-dose inhaler in patients with asthma.
    Kleerup EC; Tashkin DP; Cline AC; Ekholm BP
    Chest; 1996 Mar; 109(3):702-7. PubMed ID: 8617079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvements in delivery with an extra fine beclomethasone aerosol.
    Davies R
    Int J Clin Pract Suppl; 1998 Sep; 96():28-32. PubMed ID: 10344031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transition to CFC-free metered dose inhalers--into the new millennium.
    McDonald KJ; Martin GP
    Int J Pharm; 2000 May; 201(1):89-107. PubMed ID: 10867268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The technical transition to CFC-free inhalers.
    Tansey I
    Br J Clin Pract Suppl; 1997 May; 89():22-7. PubMed ID: 9519509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Moving from CFC aerosol to HFA aerosol or dry powder inhalers: what do patients think?
    Hartung TK; Allbutt H; Dewar M; Innes JA; Crompton GK
    Respiration; 2002; 69(4):314-9. PubMed ID: 12169743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The challenge of reformulation.
    Smith IJ
    J Aerosol Med; 1995; 8 Suppl 1():S19-27. PubMed ID: 10150491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new method to evaluate plume characteristics of hydrofluoroalkane and chlorofluorocarbon metered dose inhalers.
    Gabrio BJ; Stein SW; Velasquez DJ
    Int J Pharm; 1999 Sep; 186(1):3-12. PubMed ID: 10469919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of international environmental agreements in metered-dose inhaler technology changes.
    Forte R; Dibble C
    J Allergy Clin Immunol; 1999 Dec; 104(6):S217-20. PubMed ID: 10588977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.